Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2553 - 2560 of 12094 results

How Investors Evaluate a Company’s ESG
March 24, 2022| Blog| Viewpoint

Health Law Diagnosed: Transactions Part 2: Health Regulatory Diligence and How to Prepare for a Sell-Side Transaction
March 24, 2022| Podcast| Viewpoint

Judge Alsup Certifies Two Hot Button Issues on Standard for Pleading Willful Infringement for Interlocutory Appeal to the CAFC
March 23, 2022| Blog| Viewpoint

Telehealth Update: A Federal Appropriations Bill, A Positive OIG Report, and Good News from HHS
March 22, 2022| Blog| Viewpoint

Amazon’s Utility Patent Neutral Evaluation Proceeding: Let the Seller Beware
March 22, 2022| Blog| Viewpoint

FTC and DOJ to Host Public Forums on Effects of Mergers Ahead of Issuance of New Merger Guidelines
March 22, 2022| Blog| Viewpoint

Financing Options for Life Sciences Companies in 2022
March 21, 2022| Blog| Viewpoint

SEC Proposes New Cybersecurity Rules for Public Companies
March 21, 2022| Advisory| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
